EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access

Microplastics and nanoplastics: Emerging drivers of hepatic pathogenesis and metabolic dysfunction

Yusuf Yilmaz, Cem Simsek, Mete Ucdal, Eda Kaya

Hepatology Forum · 2025 · 6 (4) · 199-206

DOI: 10.14744/hf.2025.58577 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Hepatology Forum, 2025. Verfasst von Yusuf Yilmaz und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gastroenterology, Recep Tayyip Erdogan University School of Medicine, Rize, Türkiye. Die Arbeit wurde bisher 6-mal zitiert (Crossref). Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Advanced liver disease, including cirrhosis and hepatocellular carcino-ma (HCC), represents a major global health challenge, driven in part by the rising prevalence of metabolic dysfunction-associated steatotic liver disease (MASLD). In parallel, micro- and nanoplastics (MNPs) have emerged as pervasive environmental contaminants with potential hep-atotoxic effects. This review provides an in-depth analysis of current knowledge regarding the role of MNPs in the pathogenesis of cirrhosis and HCC, particularly in the context of the growing MASLD burden, and identifies key areas for future research. The literature search includ-ed original studies and review articles indexed in PubMed/MEDLINE, Web of Science, Scopus, and Google Scholar from January 1, 2014, to November 1, 2024. Evidence from animal models indicates that MNP exposure may induce hepatic changes resembling those seen in human MASLD and metabolic dysfunction-associated steatohepatitis (MASH) through both direct and indirect mechanisms. Importantly, MNPs may act as a “second hit” in the presence of pre-existing metabolic stress, potentially exacerbating liver injury. However, human data remain scarce, with only two small-scale studies investigating MNPs in clinical cohorts. Recent advances in analytical methods for quantifying MNPs in blood present new opportunities to explore their association with MASLD, cirrhosis, and HCC in human populations. While significant progress has been made in understanding MNP-induced hepatotoxicity in experimental models, their clinical relevance to human liver disease progression remains largely unexplored. Further multidisciplinary research integrating environmental science, molecular biology, and clinical hepatology is urgently needed.

Schlagwörter

Stichwörter der Autor:innen

Cirrhosishepatocellular carcinomahepatotoxicitymetabolic dysfunction-associated steatotic liver diseasemicronanoplastics

Autor:innen und Institutionen

  • Department of Gastroenterology, Recep Tayyip Erdogan University School of Medicine, Rize, Türkiye.
  • The Global NASH Council, Washington, DC, USA.
  • Department of Gastroenterology, Hacettepe University School of Medicine, Ankara, Türkiye.
  • Department of Internal Medicine, Hacettepe University School of Medicine, Ankara, Türkiye.
  • Department of Medicine, University Hospital Knappschaft Kliniken Bochum, Ruhr University Bochum, Bochum, Germany.

Zitieren

APA

Yilmaz, Y., Simsek, C., Ucdal, M., & Kaya, E. (2025). Microplastics and nanoplastics: Emerging drivers of hepatic pathogenesis and metabolic dysfunction. Hepatology Forum, 6(4), 199-206. https://doi.org/10.14744/hf.2025.58577

Vancouver

Yilmaz Y, Simsek C, Ucdal M, Kaya E. Microplastics and nanoplastics: Emerging drivers of hepatic pathogenesis and metabolic dysfunction. Hepatology Forum. 2025;6(4):199-206. doi:10.14744/hf.2025.58577

BibTeX
@article{Yilmaz2025,
  author = {Yilmaz, Yusuf and Simsek, Cem and Ucdal, Mete and Kaya, Eda},
  title = {Microplastics and nanoplastics: Emerging drivers of hepatic pathogenesis and metabolic dysfunction},
  journal = {Hepatology Forum},
  year = {2025},
  volume = {6},
  number = {4},
  pages = {199--206},
  doi = {10.14744/hf.2025.58577}
}
Kostenlos starten →